Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4Venous Thrombosis 2Thromboembolism 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Burkitt Lymphoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Thrombosis 1Testicular Neoplasms 1Spinal Stenosis 1Sezary Syndrome 1Sarcoma 1Resected Liver Metastases From Colorectal Cancer 1Recurrence 1Pulmonary Embolism 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Oxaliplatin 1Leucovorin 1Heparin 1Fluorouracil 1Floxuridine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resected Liver Metastases From Colorectal Cancer × Heparin × Clear all
NCT02529774 2015-08-20

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

Fudan University

Phase 2/3 Unknown
432 enrolled
Gastrointestinal

Resected Liver Metastases From Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡